Navigation Links
Vantage Health Announces That All of Its Required Tanzanian Registrations, Permits and Licenses Have Been Formally Issued, Simultaneous With Official Notification That Its Application for Phase One Evaluation of Its HIV Screening Test Kits Has Been
Date:9/16/2011

These statements are based on expectations as of the date of this press release. Actual results may differ materially from those projected because of a number of risks and uncertainties, including those detailed from time to time in the Company's reports filed with the Securities and Exchange Commission. The Company assumes no obligations and does not intend to update these forward-looking statements.

Vantage Health is a US company (OTC:BB – ticker symbol VNTH) recently incorporated and public since February 2011 with the goal of providing healthcare related products and services in sub Saharan Africa.

For more information about Vantage Health, please contact:
Dr. Lisa Ramakrishnan / Karen Sylvester
Tel:   +27 (0) 21 813 6863
Fax:  +27 (0) 86 604 7593
ceo@vantagehealth.co.za
www.vantagehealthgroup.com


'/>"/>
SOURCE Vantage Health
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib) for Injection Based Therapy Across All Endpoints
2. Facet Solutions AFRS(TM) Demonstrates Biomechanical Advantages Over Dynamic Stabilization in Independent Testing
3. Current and Emerging Drugs Have No Advantage Over Enbrel in Inhibiting/Slowing the Progression of Rheumatoid Arthritis
4. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
5. Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City
6. St. Jude Finds Young Age May Give Survival Advantage to Children With Certain Brain Tumors
7. Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs
8. Isis Announces That OGX-011 Has Shown Overall Survival Advantage in Prostate Cancer Compared to Standard Therapy in a Randomized Phase 2 Study
9. Continued Overall Survival Advantage Reported From Pivotal Trial of VELCADE(R) (Bortezomib) for Injection Based Therapy in Patients With Previously Untreated Multiple Myeloma
10. Abbotts Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years
11. Prospective Clinical Advantages of Trabecular Metal(TM) Technology Highlighted in Comparative Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Ill. , May 4, 2015 RadiologyAuction will ... with live video and product demonstrations at the end ... imaging equipment such as Kodak and Fuji Cr,s, Agfa ... auctioned at the first event. Various imaging equipment will ... www.RadiologyAuction.com . After years of buying and ...
(Date:5/4/2015)... , May 4, 2015 PharmaEngine, Inc. ... Pharmaceuticals, Inc. (NASDAQ: MACK ) with its ... ) jointly announced that Baxter has submitted a ... Agency (EMA) for MM-398 (irinotecan liposome injection), also ... of the pancreas who have been previously treated ...
(Date:5/4/2015)... Pa. , May 4, 2015  Makindus, Inc. ... today that the European Medicines Agency (EMA) has granted ... the treatment of Stargardt,s Disease. "We are ... MI-100 to treat Stargardt,s disease in place for ... development program in the United States ...
Breaking Medicine Technology:RadiologyAuction Announces Event Starting On May 5th 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 2PharmaEngine Announces Filing by Baxter BioScience of Marketing Authorization Application of MM-398 (PEP02) to the European Medicines Agency for Post-Gemcitabine Metastatic Pancreatic Cancer Patients 3European Medicines Agency (EMA) Grants Orphan Designation for Makindus' MI-100 for Stargardt's Disease 2
... , WALTHAM, Mass., Nov. 17 Decision Resources, one ... and healthcare issues, finds that sales of agents to treat ... decade, increasing from $360 million in 2008 to $450 million ... the United Kingdom and Japan. , The new Pharmacor report ...
... 16 Symmetry Medical Inc. (NYSE: SMA ), a ... and other medical markets, announced today that Brian S. Moore, President ... and Chief Financial Officer, are scheduled to present at the 21st ... New York City on Tuesday, December 1, 2009 at 12:30 p.m. ...
Cached Medicine Technology:Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018 2Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:5/4/2015)... (PRWEB) May 04, 2015 Malibu ... oral antiseptic breath spray. KissSafe™ is the first ... a safer experience while adding fresh breath appeal. ... and effectively kills germs in the mouth and ... also contains ingredients that possess additional wellness benefits. ...
(Date:5/4/2015)... Milton Hershey School® has named J. Anthony Graves, ... recognizing his commitment to pediatric cancer research and the ... students. , “Dr. Graves is a tremendous example of ... a top-notch education, a nurturing environment, and the opportunity ... ’85, president of MHS. “He is applying the values ...
(Date:5/4/2015)... Johnson & Wales University (JWU) held a groundbreaking ceremony ... on Wednesday, April 22. , Johnson & Wales becomes the ... the re-alignment of Interstate-195. JWU’s new academic building, which will ... in Providence, is scheduled to be completed in July 2016. ... university purchased in 2012. , “It has long been our ...
(Date:5/4/2015)... The opportunity for children to dream of a ... forces behind The Fairy Godmother Next Door, a new children’s ... Stark. , The inspiration for the enchanting story of a ... Stark’s desire to be a fairy godmother. , “My wish ... my neighbors’ children since they were born. We discuss fairies ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Now in ... IPC clinical leaders who have made outstanding contributions to ... they serve, both in acute and post-acute care settings. ... Year, Post-Acute Provider of the Year, Advanced Practice Clinician ... Specialist Provider of the Year. Recipients are selected by ...
Breaking Medicine News(10 mins):Health News:80 Million Germs from Kissing - Introducing KissSafe™ 2Health News:Milton Hershey School Names 2015 Alumnus of the Year 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 2Health News:Johnson & Wales University “Breaks Ground” On New $40 Million Engineering and Science Academic Center 3Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:IPC Healthcare Announces Clinicians of the Year 2Health News:IPC Healthcare Announces Clinicians of the Year 3
... NEW YORK, June 25 International superstar Beyonce will perform ... to benefit the Charles & Phyllis Newman Foundation and the ... the most widely recognized and highly respected women in pop ... album I Am . . . Sasha Fierce ...
... , , Company,s Behavioral Health Grants Now ... ValueOptions(R), Inc., of Norfolk, Virginia, the behavioral health organization ... Mexico since 2005, announced today that it is awarding $3.1 ... services across the state. , , (Logo: ...
... ... Institute (SSI) announces the launch of the National ObamaCare Opt Out (NOOO!) ... not force them to join a national healthcare system, nor to purchase ... http://www.patientoptout.com , is modeled after the National Do Not Call Registry, and ...
... ... Children with Muscular Dystrophy , ... Boston, MA (PRWEB) June 25, 2009 -- In immediate response to the Muscular Dystrophy Association,s ... virus, more commonly known as the "swine flu" Camp Promise, today announced its efforts to ...
... 25 According to Millennium Research Group (MRG), ... pharmacomechanical thrombectomy (PMT) procedure adoption will accelerate over ... interest in treating deep vein thrombosis (DVT). Although ... Adjunctive Catheter-Directed Thrombolysis) trial, which will compare catheter-directed ...
... Prompts Addition of Veteran Sales Executives to Premium Provider of ... June 25 MedPro Imaging, a premium provider of new ... sales executives in support of ongoing growth. MedPro, which recently ... quarter of 2009, has named Scott Wayman the zone manager ...
Cached Medicine News:Health News:ValueOptions(R) Reinvests $3.1 Million in New Mexico 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 2Health News:Social Security Institute Launches the National Obamacare Opt Out (NOOO!) Registry 3Health News:Camp Promise Rallies To Provide Massachusetts Children With Alternative To MDA Canceled Summer Camp 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 2Health News:Pharmacomechanical Thrombectomy Procedure Adoption to Accelerate Due to More Aggressive Treatment of Deep Vein Thrombosis, According to Millennium Research Group 3Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 2Health News:MedPro Imaging Adds Wayman and Sanford to Growing Sales Team 3
Half aprons used to protect pelvic regions...
Light and comfortable thyroid protection. The softest, most comfortable throid collar made. No neck irritating binding....
... full protection is necessary, the Two-Piece ... add to your comfort through more ... greater flexibility. The vest comes with ... hanging loops as well as an ...
... Apron has standard front protection. ... from the shoulders to the ... a 6" wide elastic belt. ... fit various sized individuals. Available ...
Medicine Products: